Navigation Links
Commissions in Medical News

BTIG To Hold 7th Commissions for Charity Day

anticipated donationS to benefit local charities NEW YORK, May 18 /PRNewswire/ -- BTIG LLC, an institutional broker dealer specializing in trading and related brokerage services, will donate equity and derivative trading commission profits earned on Tuesday, May 19 to a group of nonprofit or...

AHIP Statement on New CMS Guidelines for Agent and Broker Commissions in Medicare Advantage

WASHINGTON, Nov. 10 /PRNewswire-USNewswire/ -- Karen Ignagni, President and CEO of America's Health Insurance Plans (AHIP), today issued the following statement on new guidelines announced by CMS on agent and broker compensation for Medicare Advantage plans: "We commend CMS for taking this i...

SAFC Pharma Commissions HPAPI Conjugates Facility at St. Louis

ST. LOUIS, Sept. 29 /PRNewswire-FirstCall/ -- SAFC Pharma(TM), a focus area within SAFC(R), a member of the Sigma-Aldrich Group (Nasdaq: SIAL ), today announced details of a new suite that has been commissioned at its St. Louis campus that will produce high-potency active pharmaceutical ingre...

San Antonio Community Hospital Commissions Leksell Gamma Knife(R) Perfexion(TM) To Serve Over 3 Million Californians

ATLANTA, June 3 /PRNewswire/ -- Physicians at California's San Antonio Community Hospital in Upland, will soon treat patients using the new Leksell(R) Gamma Knife Perfexion(TM). A revolutionary alternative to traditional open-brain surgery and daily radiation treatments, Leksell Gamma Knife Pe...

Chiefs Of Regional Commissions For Animal Health Announced

Dr. Robert Thwala, the Ministry of Agriculture Director of Veterinary and Livestock Services, was anointed as President of the African Regional Commission //for the International Committee of the World Organisation for Animal Health (OIE). Dr. Barry O’Neil was earlier elected the President of...

MAP Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock

...fering of 3,500,000 shares of its common stock at a public offering price of $9.70 per share. Net proceeds, after estimated underwriting discounts and commissions and estimated expenses, will be approximately $31.4 million. MAP Pharmaceuticals has granted the underwriters of the offering a 30-day option to purc...

NHP Reports 2009 Second Quarter Results

...ation 756 777 1,570 1,524 Lease commissions and tenant and capital improvements (1,343) (1,047) ... Deferred finance cost amortization 3,120 3,120 Lease commissions and tenant and capital improvements (5,608) (5,...

West Announces Second Quarter 2009 Results

... increase included additional spending on information systems, including depreciation and other project-related costs, and outside services, including commissions and acquisition-related legal services. Research spending was substantially unchanged from the prior-year quarter. Resulting operating profit was $34...

Hospira Reports Second-Quarter 2009 Results

... $402.0 $338.3 Trade accounts payable 200.4 231.5 Salaries, wages and commissions 121.2 144.7 Deferred income taxes - 1.5 Other accrued liabilities ...

Cell Therapeutics, Inc. Announces Closing of Public Offering of Common Stock and Warrants

... overallotment option. The Company received approximately $40.3 million in net proceeds from the offering, after deducting underwriting discounts and commissions and estimated offering expenses. Each warrant has an exercise price of $1.70 per warrant share, for total potential additional gross proceeds t...
Commissions in Medical Technology

Oncolytics Biotech(R) Inc. Announces Publication of Research on Synergistic Activity of Reovirus and Chemotherapy in NSCLC

...rtainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue relian...

Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours

...rtainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue relian...

Breast Cancer Clinical Results Show Test Can Differentiate Normal, Early and Later Stage Cancers

...on for our products or product candidates. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward...

Cancer Therapy & Research Center at The University of Texas Health Science Center and Oncolytics Biotech(R) Inc. Announce Multi-Trial Clinical Research Collaboration

...rtainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward looking statements. Investors are cautioned against placing undue relian...

Oncolytics Biotech Inc. Announces Start of Patient Enrolment in Translational Clinical Trial Investigating REOLYSIN(R) in Patients with Metastatic Colorectal Cancer

...rtainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward looking statements. Investors are cautioned against placing undue relian...

PreMD Inc. Enters Clinical Study with Cosmetics Conglomerate

... for our products or product candidates. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward...

AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108

... and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward...

U.S. NCI Starts Enrolment in Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN(R)

...rtainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward looking statements. Investors are cautioned against placing undue relian...

Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement

...ly market products, and other factors which may be beyond the control of either Transition or Lilly. Please see Transition's filings with the Canadian commissions and Lilly's filings with the U.S. Securities and Exchange Commission for further information about risk factors and other cautionary statements. Neith...

Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement

...n Stock at a price of $0.65 per share resulting in gross proceeds of $650,000. WestPark Capital, Inc. acted as placement agent and received $65,000 in commissions and $26,000 representing a non-accountable expense fee. Lixte also issued to WestPark five year warrants to purchase up to 100,000 shares of the Compa...
Commissions in Biological News

Britain's last Neanderthals were more sophisticated than we thought

...s south east England. The project now aims to prospect more widely across the region for similar sites. Barney Sloane, Head of Historic Environment commissions at English Heritage, said: "Sites such as this are extremely rare and a relatively little considered archaeological resource. Their remains sit at a k...

Unmanned aircraft to study Southern California smog and its consequences

...g effects for the first time over California, and this data will likely help California reduce its global warming commitment. The California Energy commissions Public Interest Energy Research (PIER) program will employ CAPPS results in an analysis of the potential future economic and ecological consequences o...

Proposal to step up cardiovascular disease research

... existing projects, and in particular the European Vascular Genomics Network (EVGN), which has been running since January 2004 as part of the European commissions FP6 framework research programme. EVGN has been promoting multidisciplinary interaction between 30 world class basic and clinical institutions in 11 E...

Tiny fish can yield big clues to Delaware River health

...e new habitats for the bridle shiner. The results of the Academys studies, which will continue into 2008, will factor into the Delaware River Basin commissions flow management plans for the river. Bridle shiner prefer slow-moving, shallow waters that flow over beds of aquatic plants. The Upper Delaware River ...
Commissions in Biological Technology

PEAT International Commissions Plasma-Based Waste Treatment Facility Designed Specifically for Onsite Waste Processing

- Marks the first deployment of the system intended for hospitals and industrial facilities - NORTHBROOK, Ill., and ANKLESHWAR, India, April 23 /PRNewswire/ -- PEAT International, Inc., ("PEAT") a global leader in plasma-based waste remediation solutions, announced toda...

Exciton Technologies receives FDA approval to market exSALT(TM)

...sequently shown to be invalid or infringe the patents of others. Investors should consult the Company's quarterly and annual filings with the Canadian commissions for additional information on risks and uncertainties relating to the forward- looking statements. Investors are cautioned against placing undue relia...

Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock

...ounced the pricing of an underwritten offering of 7,248,936 shares of its common stock at a price of $3.14 per share. After underwriting discounts and commissions and estimated offering expenses, the company expects to receive net proceeds of approximately $21.2 million. All of the shares are being sold by Iden...

AEterna Zentaris Partner, Keryx, Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial with Perifosine (KRX-0401) for the Treatment of Multiple Myeloma

... and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward...

Oncolytics Biotech(R) Inc. Announces 2009 Second Quarter Results

...general changes to the economic environment. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue relian...

Oncolytics Biotech Inc. Successfully Completes 100-Litre cGMP Production of REOLYSIN(R)

...rtainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue relian...

Orexigen(R) Therapeutics Announces Full Exercise of Overallotment Option by Underwriters

... of $7.50 per share, resulting in expected net proceeds to the company of approximately $81.6 million (after payment of the underwriting discounts and commissions and estimated expenses). Leerink Swann LLC acted as sole book-running manager for the offering. Lazard Capital Markets LLC, Canaccord Adams ...

Cell Therapeutics, Inc. Announces Exercise of Overallotment

...common stock, for aggregate gross proceeds of approximately $43.9 million. The net proceeds to the Company after deducting underwriting discounts and commissions and estimated offering expenses are expected to be approximately $40.3 million. Each warrant has an exercise price of $1.70 per warrant share...

Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement

...irstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX: ANP) today filed a preliminary short form base shelf prospectus with the securities commissions of British Columbia and Ontario and a corresponding shelf registration statement on Form S-3 with the United States Securities and Exchange Commission...

Cell Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock and Warrants

...954 additional shares of its common stock to cover overallotments, if any. The net proceeds to the Company after deducting underwriting discounts and commissions and estimated offering expenses, excluding any exercise of the underwriter's overallotment option, are expected to be approximately $35.0 million. ...
Other Tags
(Date:7/9/2014)... feelings are personal and subjective, the human brain ... represents emotions across different senses, situations and even ... neuroscientist Adam Anderson. , "We discovered that fine-grained ... an area of the brain associated with emotional ... an individual,s subjective feeling," says Anderson, associate professor ...
(Date:7/9/2014)... There has been a sharp increase in the ... using MyChart, the online, interactive service that allows patients ... healthcare providers, schedule appointments, and renew prescriptions. , Over ... MyChart each year increased five-fold, while the ... 10-fold, according to a study by Dr. David ...
(Date:7/9/2014)... declines and extinctions around the world have been ... but new research from the National Institute for ... pathogen, ranavirus, may also contribute. , In ... ranavirus, which causes severe hemorrhage of internal organs ... of wood frogs if they are exposed to ...
(Date:7/9/2014)... flatulence and have a reputation for being highly toxic, but ... now being being found to offer potential health benefits in ... and dementia. A new compound (AP39), designed and made at ... therapies, by targeting delivery of very small amounts of the ... , Scientists in Exeter have already found that the compound ...
(Date:7/9/2014)... the most important organs in the human body. Its ... properly this is its synthesis function and ... this is its detoxification function. Lack of exercise and ... the liver. The resulting diseased cells can lead to ... failure. According to the German Liver Foundation, over five ...
Breaking Medicine News(10 mins):Health News:Study cracks how the brain processes emotions 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3Health News:Study predicts ranavirus as potential new culprit in amphibian extinctions 2Health News:Rotten egg gas holds key to healthcare therapies 2Health News:Telemedicine for patients with chronic liver diseases 2Health News:Telemedicine for patients with chronic liver diseases 3
(Date:7/9/2014)... of studies suggest that children delivered by Caesarean section have ... But it is still unknown why this is the case ... the Faculty of Health and Medical Sciences therefore decided to ... immune system in a study of newborn mouse pups. ... Caesarean section had developed a lower number of cells that ...
(Date:7/9/2014)... switch out one gene for another in a line ... fiction to reality within this decade. As with any ... of fixing disease-causing genes in humans, for example--as well ... put one of those concerns to rest: using gene-editing ... of mutations in the cells. The new results were ...
(Date:7/9/2014)... Ind. - Regulated deer hunts in Indiana state parks ... decades of damage caused by overabundant populations of white-tailed ... led by Michael Jenkins, associate professor of forest ecology, ... policy of organizing hunts in state parks has successfully ... wildflowers rendered scarce by browsing deer. , Jenkins ...
Breaking Biology News(10 mins):Mouse study: Natural birth may strengthen the immune system 2No extra mutations in modified stem cells, study finds 2No extra mutations in modified stem cells, study finds 3Hunting gives deer-damaged forests in state parks a shot at recovery 2
Other Contents